Pfizer Inc. Stock Sao Paulo

Equities

PFIZ34

BRPFIZBDR006

Pharmaceuticals

Market Closed - Sao Paulo 04:05:00 2024-04-23 pm EDT 5-day change 1st Jan Change
33.7 BRL -1.17% Intraday chart for Pfizer Inc. -0.53% -2.83%
Sales 2024 * 59.96B 308B Sales 2025 * 62.57B 321B Capitalization 149B 765B
Net income 2024 * 6.75B 34.61B Net income 2025 * 9.29B 47.66B EV / Sales 2024 * 3.27 x
Net Debt 2024 * 47.04B 241B Net Debt 2025 * 41.91B 215B EV / Sales 2025 * 3.05 x
P/E ratio 2024 *
19.3 x
P/E ratio 2025 *
14 x
Employees 88,000
Yield 2024 *
6.44%
Yield 2025 *
6.61%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.17%
1 week-0.53%
Current month-3.44%
1 month-1.86%
3 months-4.32%
6 months-12.63%
Current year-2.83%
More quotes
1 week
33.20
Extreme 33.2
34.25
1 month
33.12
Extreme 33.12
35.19
Current year
31.66
Extreme 31.66
37.10
1 year
31.66
Extreme 31.66
51.00
3 years
31.66
Extreme 31.66
88.24
5 years
31.66
Extreme 31.66
88.24
10 years
16.04
Extreme 16.035
88.24
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-04-23 33.7 -1.17% 1,082
24-04-22 34.1 +0.44% 11,206
24-04-19 33.95 +2.04% 7,749
24-04-18 33.27 -0.54% 2,758
24-04-17 33.45 -1.27% 6,504

Delayed Quote Sao Paulo, April 23, 2024 at 04:05 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26.32 USD
Average target price
31.62 USD
Spread / Average Target
+20.14%
Consensus